Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1049 of 5804
-
New drug trial targets rare, aggressive cancer subtype
Disease control Recruiting nowPhase II open label study designed to evaluate the efficacy and safety of P-Sam in patients with aggressive, solid, NOTCH mutant or p63 low (B7-H4 high) R/M ACC-I patients.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Brain cancer radiotherapy gets a precision boost from advanced MRI
Disease control Recruiting nowThis is a research study to determine if a novel molecular magnetic resonance imaging (MRI) technique, called amide proton transfer (APT) imaging, is useful in identifying the most aggressive areas of tumor needed for radiotherapy of brain tumors.
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Robot companions take on dementia apathy: a new hope for caregivers?
Symptom relief Recruiting nowThe goal of this trial is to learn whether home-based robotic interventions can reduce apathy in people with cognitive decline. Apathy means reduced motivation, interest, or initiative in daily life. It is a common and distressing symptom in people with mild cognitive impairment …
Phase: NA • Sponsor: Giovanna Zamboni • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Touch and tingle: Non-Invasive therapies take on ringing ears
Symptom relief Recruiting nowTinnitus is a common neurosensory symptom affecting 12-30% of adults and is closely associated with anxiety, sleep disturbance, and autonomic dysregulation. Current pharmacologic treatments offer limited efficacy and notable side effects, prompting interest in non-pharmacological…
Phase: NA • Sponsor: Tzu Chi University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New drug aims to protect hearts after bypass surgery
Disease control Recruiting nowADR-002K is administered to heart failure patients with ischemic heart disease who undergo coronary artery bypass surgery (CABG) to investigate its efficacy and safety.
Phase: PHASE2 • Sponsor: Rohto Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
AI reads your Heart's electrical signals to catch hidden valve disease
Diagnosis Recruiting nowAoS-SEDAI study is an observational, multicenter, retrospective and prospective clinical study. This study aims to assess Willem Artificial Intelligence (AI) ability to distinguish between aortic stenosis (AS) and non-AS patients from 12-lead electrocardiogram (ECG) data.
Sponsor: Idoven 1903 S.L. • Aim: Diagnosis
Last updated Jul 22, 2026 00:00 UTC
-
Could a single injection reprogram immune cells to tame lupus and scleroderma?
Disease control Not yet recruitingThis is an open-label, single-arm study designed to evaluate the safety and preliminary efficacy of HN2302 in patients with autoimmune diseases, including systemic lupus erythematosus (SLE) and systemic sclerosis (SSc).
Phase: PHASE1 • Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
AI-Designed mRNA vaccine takes on advanced tumors in first human test
⭐️ VACCINE ⭐️ Recruiting nowThis is a phase I, open-label, single-arm, single-center, dose-escalation study to evaluate the safety, tolerability, and preliminary anti-tumor efficacy of PAN-NeoVax, an artificial intelligence (AI)-designed pan-cancer neoantigen mRNA vaccine delivered via lipid nanoparticles (…
Phase: PHASE1 • Sponsor: West China Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:32 UTC
-
Virtual reality could help prevent eating disorders in At-Risk youth
Prevention Recruiting nowThe aim of this study is to evaluate the feasibility and preliminary effects of PrevED MR, a group-based preventive intervention for adolescents and young adults at risk of developing eating disorders. PrevED MR is based on dialectical behavior therapy skills and uses mixed reali…
Phase: NA • Sponsor: Universitat Internacional de Catalunya • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Shorter radiation course for esophageal cancer shows promise in new trial
Disease control Recruiting nowThe goal of this clinical trial is to learn if hypofractionation of definitive chemoradiotherapy can treat patients with locally advanced esophageal cancer. The main question it aims to answer is if this treatment is feasible and safe. We also want to investigate the toxicity, in…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New radiation method targets tough tumors
Disease control Recruiting nowTo assess the importance of using SBRT-LATTICE-PATHY for the radiotherapy treatment of large tumors that would be considered intractable by currently used standard techniques. In this present study, the investigators will have the possibility of combining SBRT and LATTICE techniq…
Phase: PHASE2 • Sponsor: University of Sao Paulo General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Targeted radiation and immunotherapy join forces against Hard-to-Treat lung cancer
Disease control Recruiting nowThis is a prospective, single-center, open-label investigator-initiated study designed to evaluate the safety, tolerability, radiation dosimetry, biodistribution, and preliminary antitumor activity of \[177Lu\]Lu-RTX-2358 in combination with immune checkpoint inhibitors (ICIs) in…
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Could a multiple sclerosis drug help save insulin cells in type 1 diabetes?
Disease control Recruiting nowThis is a non-randomized, parallel-controlled, single-center, open-label clinical trial designed to evaluate the efficacy of dimethyl fumarate in preserving pancreatic beta-cell function in adults with type 1 diabetes, as well as its safety and tolerability in this population. E…
Phase: PHASE2, PHASE3 • Sponsor: Nanjing Medical University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Robot coach helps kids recover from brain injury at home
Disease control Recruiting nowThis study describes a prospective, longitudinal, randomized controlled trial evaluating Inrobics Rehab, a CE-marked Class I medical device (reg. RPS/777/2021) that combines socially assistive robotics with virtual training for pediatric rehabilitation. The trial will assess usab…
Phase: NA • Sponsor: Inrobics Social Robotics, S.L. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New Non-Contact laser could make glaucoma treatment easier
Disease control Recruiting nowThis study compares two FDA-approved laser treatments for glaucoma: Direct Selective Laser Trabeculoplasty (DSLT) and Selective Laser Trabeculoplasty (SLT). Both procedures aim to lower eye pressure and prevent vision loss. DSLT is a newer, non-contact technique that may improve …
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a seizure drug also prevent sudden death in dravet syndrome?
Disease control Recruiting nowThis study investigates cerebrovascular reactivity (CVR) and functional brain connectivity in Dravet Syndrome (DS) patients with convulsive seizures. Using functional MRI (fMRI), we will define differences in brain responses to CO₂ changes before administration of the drug Fintep…
Phase: PHASE4 • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New eye implant shows promise for Long-Term wet AMD control
Disease control Recruiting nowStudy to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants with Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Phase: PHASE3 • Sponsor: Ocular Therapeutix, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for advanced colon cancer patients who've run out of options
Disease control Not yet recruitingTo evaluate the safety and efficacy of SHR-3821 combined with fruquintinib in the advanced colorectal cancer after failure of standard therapy
Phase: PHASE2 • Sponsor: Meng Qiu • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New PET scan agent aims to sharply detect multiple cancers
Diagnosis Recruiting nowThe goal of this clinical trial is to evaluate the diagnostic value of CAIX protein specific probe 18F-T2 in PET/CT imaging in participants with solid tumors. It will also assess the safety, tolerability and radiation dosimetry of 18F-T2.
Phase: NA • Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
New inhaler could ease IUD insertion pain
Symptom relief Recruiting nowIntrauterine device (IUD) insertion is a common contraceptive procedure often associated with moderate to severe pain, particularly among nulliparous individuals. Current pain management strategies, such as over-the-counter analgesics, are frequently inadequate. Methoxyflurane, a…
Phase: PHASE4 • Sponsor: Women's College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC